In particular, proinflammatory LCN2 is regulated by a transcription factor NF-κBp65 [8,11,12], so it has been suggested that LCN2 levels can potentially be a biomarker for obesity-induced metabolic disorders [4]. Here, LCN2 is linked to metabolic disease.